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ABSTRACT
Background: Doppler echocardiography is
the most frequent method for detecting and
evaluating the severity of valvular aortic
stenosis. The aim of this study was to assess
the variability and reproducibility of
echocardiographic parameters including
aortic valve area (AVA), peak aortic jet
velocity (Vmax), velocity ratio (VLVOT/Vmax),
peak gradient (Gmax) 
and mean gradient (Gmean) in aortic
stenosis (AS) patients.
Methods: Doppler echocardiograms were
obtained from 150 randomly selected
patients  (56.7% male; mean age 73±9
years) with asymptomatic moderate aortic
valve stenosis. The echocardiographic 
measurements were performed by two inde-
pendent level III (expert) blinded observers.
To assess intra-observer variability, we eval-
uated parameters of AS progression at two
different times (mean of two weeks after the
first examination).
Results: For intra-observer variability
(observer 1), the variation and reproducibili-
ty coefficients were, respectively, 1.88%
and 0.16 m/s for Vmax, 2.08% and 0.14 for
VLVOT/Vmax, 2.05% and 0.18 cm2 for AVA,
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RESUMO
Introdução: A ecocardiografia Doppler é o
método mais frequente de detecção e
avaliação da gravidade da estenose valvular
aórtica. O objectivo deste estudo foi avaliar
a variabilidade e reprodutibilidade dos
parâmetros ecocardiográficos como a área
valvular aórtica (AVA), velocidade pico
(Vmax), relação de velovidades (VLVOT/Vmax),
gradiente pico (Gmax) e gradiente médio
(Gmédio) nos doentes com estenose aórtica. 
Métodos: Um ecocardiograma Doppler foi
realizado em 60 doentes consecutivos
seleccionados aleatoriamente (da população
do estudo RAAVE) com estenose aórtica
moderada a grave assintomática (56.7%
sexo masculino; idade média 73 ± 9 anos).
As medidas ecocardiográficas foram
efectuadas por dois ecocardiografistas de
nível III numa estratégia de dupla
ocultação. Para o estudo da variabilidade
intra-observador, avaliamos os prâmetros de
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3.89% and 5.18 mmHg for Gmax and 7.87%
and 6.30 mmHg for Gmean. For inter-observer
variability, the variation and reproducibility
coefficients were, respectively, 2.00% and
0.14 m/s for Vmax, 2.91% and 0.14 for
VLVOT/Vmax, 7.67% and 0.16 cm2 for AVA,
8.53% and 7.06 mmHg for Gmean and 3.90%
and 5.58 mmHg for Gmax. Both intra- and
inter-observer studies showed excellent intr-
aclass correlation coefficients (ICC) for all
echocardiographic parameters (ICC ranged
from 0.943 to 0.990 for intra-observer vari-
ability and from 0.955 to 0.992 for inter-
observer variability).
Conclusion: Doppler echocardiographic
measurements of AVA, Vmax, Gmax and Gmean
are highly reproducible when performed by
expert observers. Of all echocardiographic
parameters, Vmax and VLVOT/Vmax showed the
best variability and reproducibility, and thus
constitute reliable tools for clinical and
research purposes in aortic stenosis 
diagnosis and follow-up.
Key words
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momentos diferentes (média de duas
semanas após o 1.º exame). 
Resultados: No que respeita à variabilidade
intra-observador (observador 1), os
coeficientes de variação e reprodutibilidade
foram, respectivamente, 1.88% e 0.16 m.s-1
para a Vmax, 2.08% e 0.14 cm2 para a
VLVOT/Vmax, 2.05% e 0.18 ms-1 para a
AVA, 3.89% e 5.18 mmHg para Gmax and
7.87% e 6.30 mmHg para o Gmédio. No
que respeita à variabilidade inter-
-observador, os coeficientes de variação e
reprodutibilidade foram, respectivamente,
2.00% e 0.14 m.s-1 para a Vmax, 2.91% e
0.14 m.s-1 para a relação VLVOT/Vmax,
7.67% e 0.16 cm2 para a AVA, 8.53% e
7.06 mmHg para o Gmédio e 3.90% e 
5.58 mmHg para o Gmax. Os estudos 
intra-observador e inter-observador
mostraram ter excelentes coeficientes de
correlação intra-classe (CCI), para todos os
parâmetros ecocardiográficos (CCI varia de
0.943 até 0.990 para a variabilidade intra-
-observador e de 0.955 até 0.992 para a
variabilidade inter-observador). 
Conclusões: As medições ecocardiográficas
da AVA, Vmax, Gmax and Gmédio são
altamente reprodutíveis quando realizadas
por ecocardiografistas experientes. De todos
os parâmetros ecocardiográficos a Vmax e a
relação VLVOT/Vmax apresentam os
melhores valores de variabilidade e
reprodutibilidade e assim constituem
provavelmente a melhor ferramenta no
diagnóstico e seguimento criterioso dos
doentes com estenose valvular aórtica.
Palavras Chave:
Estenose aórtica; Ecocardiografia; Variabilidade e
reproducibilidade; Bland-Altman; Estudo RAAVE;
Seguimento e prognóstico 
INTRODUCTION
Calcific aortic stenosis (AS) is common andhemodynamically significant valvular
stenosis affects approximately 5% of people
aged 75 to 86 years(1).  Severe symptomatic
aortic stenosis has a poor prognosis and the
only definitive treatment is aortic valve
replacement(2). The rate of disease progression
is not well known and patients with mild to
moderate aortic stenosis require regular clini-
cal and echocardiographic surveillance(3, 4).
Doppler echocardiography has become the
accepted mode of surveillance for patients
with aortic stenosis, avoiding the need for
repeated cardiac catheterization.  Results
have been shown to correlate well with inva-
sive hemodynamic data(5-7).
Calculation of aortic valve area (AVA) by
the continuity equation requires precise
measurements of the left ventricular (LV) out-
flow tract (LVOT) diameter, and peak veloci-
ties of blood flow in the LVOT and across the
aortic valve(8, 9).
Failure to acquire satisfactory images of
the LVOT can be a major limitation in a sig-
nificant proportion of patients because of body
habitus, sigmoid interventricular septum, or
aortic valve calcification(10, 11).
The continuity equation further amplifies
error by using the square of the LVOT diame-
ter to calculate cross-sectional area, con-
tributing to significant intra- and inter-observ-
er variability.
Reproducibility studies are designed to
measure the level of concordance between
observations made under the same circum-
stances by the same observer (intra-observer
concordance) or by different observers (inter-
observer concordance). Intra-observer vari-
ability is predominantly random, while inter-
observer variability can be random or system-
atic.
A measurement is said to be reproducible
if it comes from a reproducible procedure, that
is, the same measurements will be obtained if
it is repeated under the same conditions. Lack
of reproducibility in measurements can lead to
major scientific, clinical and medical-legal
consequences. Sometimes, the lack of repro-
ducibility obtained from several measure-
ments can only be improved by basing deci-
sions on multiple, independent, arbitrated or
consensual opinions.
In a biomedical study the only source of
variability in parameters should be the intrin-
sic biological variability of the subjects under
study. However, there is also very often vari-
ability which depends on measurements made
by the observer or by the tool used for the
measurements.
Accurate measurements are sometimes
needed in situations in which they are difficult
to obtain in clinical practice, with wide vari-
ability in observations that can limit their
validity.
Previous studies on reproducibility analyz-
ing this problem have mainly evaluated the
correlation more than the concordance of
measurements, which is the main reason we
have used Bland-Altman analysis.
The aim of this study was to assess the
parameters of reproducibility of echocardio-
graphic measurements in aortic stenosis
patients.
METHODS
Patients and echocardiographic meas-
urements
One hundred and fifty patients with
asymptomatic moderate calcific aortic steno-
sis and AVA ≥1.0 cm2 (56.7% male; mean age
73±9 years) were included in this Rosuvas-
tatin Affecting Aortic Valve Endothelium to
Slow the Progression of Aortic Stenosis
(RAAVE) sub-study. We decided to include
moderate AS because within this level of
severity there is a wide range of variability.
The local research ethics committee approved
the study and written informed consent was
obtained from all participants. The patients
were randomly selected from the total study
population of the RAAVE study.
Comprehensive transthoracic echocardio-
grams were performed in a single echocar-
diographic laboratory. Immediate physician 27
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review (level III) enabled re-imaging for qual-
ity control. Standard Doppler measurements
of the LVOT and aortic valve were recorded
from multiple windows to obtain the maximum
velocity, and the mean gradient, peak velocity,
and aortic valve area were measured and cal-
culated as defined by the American Heart
Association/American College of Cardiology
guidelines for the clinical application of
echocardiography(12, 13).
To assess intra-observer variability, we
evaluated parameters of aortic stenosis pro-
gression (peak velocity, aortic valve area, peak
gradient, mean gradient and VLVOT/Vmax
ratio) at two different times (two weeks after
the first examination).
For inter-observer variability, off-line mea-
surements were made from the records by a
second observer who was unaware of the
results of the first studies.
The echocardiograms were performed by
two echocardiographers with over five years of
experience (IB and LM).
The images were recorded digitally and
analyzed off-line. A total of five measurements
of each parameter were made for patients in
sinus rhythm and seven for patients with atri-
al fibrillation, and the mean of these measure-
ments was used.
Statistical analysis
Data are presented as mean ± standard
deviation. The variability of the measurements
was evaluated based on the variability coeffi-
cient.  Reproducibility was assessed by the
interclass correlation coefficient (ICC).
In addition, the Bland-Altman method (14) (the
mean of the differences ± twice the standard
deviation of the differences) was used to calcu-
late the reproducibility coefficient. This method
is an excellent tool for examination of models
with discordance between measurements, as its
graphical nature makes it easier to interpret.
The Student’s t test for paired samples was
used to verify whether the mean of the differ-
ences between the measurements (different
observers or different times) was statistically
equal to zero. Analyses were performed using
SPSS software, version 14.0 (SPSS Inc.,
Chicago, Illinois). A two-tailed p value less
than 0.05 was considered to indicate statisti-
cal significance.
RESULTS
Intra-observer variability and repro-
ducibility
Comparisons of variables for both observer
1 and observer 2 are shown as coefficients of
variation (Table I), as reproducibility coeffi-
cients and as ICCs (Table II), and as a Bland-
Altman plot in Figure 1.
The variation coefficients (Table I) were
proportionately better, corresponding to a
small variation, for Vmax (observer 1 = 1.88%;
observer 2 = 5.86%), VLVOT/Vmax (observer 1 =
2.08%; observer 2 = 2.15%) and for Gmax
(observer 1 = 3.89%; observer 2 = 4.12%)
than for AVA (observer 1 = 2.05%; observer 2
= 7.89%) and Gmean (observer 1 = 7.87%;
observer 2 = 6.67%).
The intra-observer reproducibility coeffi-
cients (Table II) were 0.16 m/s for Vmax, 0.14
for VLVOT/Vmax and 0.18 cm2 for AVA. For Gmax
and Gmean, reproducibility coefficients were
5.18 mmHg and 6.30 mmHg, respectively.
When the null hypothesis was verified the
mean difference of measurements (obtained at
two different times) was equal to zero, and this
cannot be rejected for the variables analyzed
(p≥0.251).
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Coefficient of variation Coefficient of variation 
Observer 1 Observer 2 
Vmax (m/s) 1.88% 5.86% 
AVA (cm2) 2.05% 7.89% 
Gmax (mmHg) 3.89% 4.12% 
+ Gmean (mmHg) 7.87% 6.67% 
+ VLVOT /Vmean 2.08% 2.15% 
Table I.  Intra-observer variability of echocardiography measurements of AS 
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Mean ± SD  Mean ± SD of the RC ICC p*
differences     
Vmax (m/s)            3.51±0.55 0.01±0.08  0.16 0.989 0.479   
AVA (cm2) 1.01±0.32  0.00±0.09 0.18 0.969 0.966 
Gmax (mmHg) 50.56±16.50 0.29±2.59 5.18 0.957 0.550 
Gmean (mmHg) 33.44±11.47 0.74±3.15 6.30 0.943 0.251 
VLVOT/Vmax 0.31±0.05 0.01±0.07 0.14 0.990 0.729 
Table II. Intra-observer reproducibility of echocardiographic measurements of AS
* The hypotheses of the test are H0: dmean (mean difference) = 0 vs. H1: dmean ≠ 0. RC: reproducibility coefficient: twice the standard
deviation of the differences, ICC: intraclass correlation coefficient.
Figure 1. Intra-observer reproducibility (A-E) of echocardiographic measurements of aortic valve stenosis. The central horizontal line
corresponds to the mean of the differences of the two measurements and the two exterior lines correspond to 2 x SD of the differences.
Coefficient of variation
Vmean (m/s) 2.00% 
AVA (cm2) 7.67% 
Gmax (mmHg) 3.90% 
Gmean (mmHg) 8.53% 
VLVOT/Vmax 2.91% 
Table III. Inter-observer variability of echocardiographic measurements of AS
* The hypotheses of the test are H0: dmean (mean difference) = 0 vs. H1: dmean ≠ 0. RC: reproducibility coefficient: twice the standard
deviation of the differences, ICC: intraclass correlation coefficient.
Whichever variables were analyzed, excel-
lent intraclass correlation coefficients were
obtained (Table II), reflecting excellent accu-
racy in measurements of all echocardiograph-
ic variables.
The distribution of the points in Figure 1
(A-E) shows that there were no systematic
errors in the readings made by the observer.
Among the echocardiographic variables
studied, Vmax and VLVOT/Vmax provide better per-
formance for the evaluation of aortic stenosis
(lower variation coefficient and higher ICC).
Inter-observer variability and 
reproducibility
Comparisons between observers 1 and 2
are presented as coefficients of variation
(Table III), as reproducibility coefficients and
as ICCs (Table IV), and as a Bland-Altman
plot in Figure 2 (A-E).
In analysis of inter-observer variability,
Table III shows that coefficients of variation
were better for Vmax (2.00%) and VLVOT/Vmax
(2.91%) than for Gmax (3.90%), AVA (7.67%)
and Gmean (8.53%).
As can be seen in Table IV, the coefficients
of inter-observer reproducibility were 0.14
m/s for Vmax, 0.14 for VLOVT/Vmax and 0.16 cm2
for AVA. For Gmax and Gmean, the reproducibility
coefficients were 5.58 mmHg and 7.06
mmHg, respectively. When the hypothesis was
proven, the mean differences in the measure-
ments between the two observers were equal
to zero, so this hypothesis cannot be rejected
for the variables analyzed (p≥0.495).
The distribution of the points in Figure 2
(A-E) suggests that there is no divergence in
the observations produced by the two
observers. In addition, excellent intraclass
correlation coefficients were recorded (Table
IV) (r=0.992 for Vmax, r=0.989 for  VLVOT/Vmax,
r=0.967 for AVA, r=0.961 for Gmax and r=0.995
for Gmean).
We obtained a correlation coefficient (r) for
AVA for 2D echocardiography vs. catheteriza-
tion of 0.71 in 12 patients who were referred
for aortic valve replacement surgery.
DISCUSSION
What is in fact the clinical utility of these
data in an era when multimodality imaging is
becoming more and more relevant and echo
has been shown to be a reproducible imaging
technique? What does it add to the body of
current knowledge that will make clinicians
rely even further on it? Will these results in
any way alter clinical practice?
Additionally, we believe there is some con-
fusion among scientists and statisticians about
the right test to assess inter- and intra-observ-
er variability. What does this really add over
and above analysis of variance, standard devi-
ation and simple averages?
To start to answer to these questions we
already know that assessment of aortic stenosis
requires evaluation of patient symptoms and
quantification of the severity of valve obstruc-
tion. Methods to assess severity include cardiac
catheterization, echocardiography, intravascu-
lar ultrasound, computed tomography, and
magnetic resonance imaging. The ideal method
should be simple, noninvasive, and widely
available while remaining both accurate and
reproducible; echocardiography would seem to
best fulfill these requirements.30
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Mean ± SD  Mean ± SD of the RC ICC p*
differences     
Vmax (m/s)            3.51±0.55 0.00±0.07  0.14 0.992 0.980   
AVA (cm2) 1.01±0.32  -0.01±0.08 0.16 0.967 0.495 
Gmax (mmHg) 50.56±16.50 0.02±2.79 5.58 0.961 0.962 
Gmean (mmHg) 33.44±11.47 0.38±3.53 7.06 0.955 0.592 
VLVOT/Vmax 0.34±0.09 0.01±0.07 0.14 0.989 0.909
Table IV. Inter-observer reproducibility of echocardiographic measurements of AS
* The hypotheses of the test are H0: dmean (mean difference) = 0 vs. H1: dmean ≠ 0. RC: reproducibility coefficient: twice the standard
deviation of the differences, ICC: intraclass correlation coefficient.
High standard deviations were observed in
the hemodynamic progression of AS, high-
lighting the considerable individual variabili-
ty in disease progression.
Calculation of aortic valve area according
to the continuity equation is a reliable and
reproducible method for evaluating the sever-
ity of aortic stenosis. However, it requires
accurate measurements, because a calculation
error could be amplified proportionally to its
square (for example, in determination of the
diameter of the LVOT), which contributes to
greater intra- and inter-observer variability,
thus limiting its validity in some cases.
Other works studying these problems
mainly evaluated correlation rather than con-
cordance of data (14). We calculated the vari-
ability of observations based on the variation
coefficient and difference between two meas-
urements as the percentage of the mean (10, 15-18). 31
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Figure 2. Inter-observer reproducibility (A-E) of echocardiograph-
ic measurements of aortic valve stenosis. The central horizontal
line corresponds to the mean of the differences of the two measure-
ments and the two exterior lines correspond to 2 x SD of the differ-
ences.
However, as these coefficients do not show
potential systematic errors, we calculated the
reproducibility coefficient, which does not
vary with the value of the mean. Prior findings
on inter-observer variability for AVA indicate
that this can reach up to 24%, although stud-
ies assessing reproducibility that use regres-
sion analysis should be interpreted with cau-
tion (18).
In this study, peak aortic jet velocity and
the VLVOT/Vmax ratio (interrelated by the
Bernoulli equation) demonstrated lower val-
ues of intra-and inter-observer variation.
Similarly, these two parameters already had
the best correlation coefficients. This shows
that an increase in peak transvalvular veloci-
ty on AS follow-up constitutes the earliest sign
of disease progression and is the best parame-
ter revealing AS severity because it evaluates
the vena contracta (anatomical area).
The coefficients of variation of AVA are
similar to those in the literature, which con-
firms the clinical limitations of this parameter
in monitoring AS progression over time (19).
Recall we obtained a correlation coefficient (r)
for AVA for 2D echocardiography vs. catheter-
ization of 0.71. New methods such as real-
time 3D echocardiography (RT3D) will proba-
bly be more accurate than 2D echocardiogra-
phy and two-dimensional volumetric methods
to calculate the area and to grade the severity
of AS (20). In the near future evaluating AVA by
RT3D will probably demonstrate the best
agreement among all techniques. Planimetry
of the aortic valve by transesophageal
echocardiography shows good correlation with
the Gorlin equation and with the continuity
equation by RT3D, but this parameter is by
itself rarely sufficient for making clinical
decisions.
As in other published papers, our study
shows through serial measurements that peak
transvalvular velocity and aortic valve area
are the parameters with least variability and
best reproducibility for the evaluation and fol-
low-up of patients with AS.
Using the same rationale we additionally
propose that the VLVOT/Vmax ratio, i.e. peak trans-
valvular velocity (CW) divided by LLVOT peak
velocity (PW), is a better parameter to evalu-
ate AS progression. This ratio is another
approach to reducing error related to LVOT
diameter measurements by removing cross-
sectional area (CSA) from the simplified con-
tinuity equation. This dimensionless velocity
ratio expresses the size of the effective valve
area as a proportion of the CSA of the LVOT.
A normal velocity ratio is slightly less than 1,
with smaller ratios indicating more severe aor-
tic stenosis. For example, a velocity of 0.25 (21)
means that the valve opening is reduced to
one-fourth (25%) its normal size. The velocity
ratio has the advantage of being already
“indexed” to body size. Normal intra-cardiac
velocities are similar in people of all ages and
sizes. By looking at the velocities alone, the
velocity ratio assumes that the proximal cross-
sectional area is “normal” for the patient and
thus the resulting descriptor of stenosis sever-
ity is indexed for body size (22).
Therefore, we suggest their routine use in
quantification of AS, especially when techni-
cal doubts arise (deficient acoustic windows)
or when other measurements are close to the
limits of different degrees of severity.
The major clinical implications and utility
of this study are that it has demonstrated,
using appropriate methodology (Bland-
Altman plots), that velocity  ratio is the most
useful parameter to follow aortic stenosis
patients in the long term. We came to this con-
clusion on the basis of findings in previous
studies on this topic and after correlation with
angiographic data.
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